猩红热近十年中西医研究概述与展望

Overview and prospect of research on scarlet fever in traditional Chinese and western medicine in the last decade

猩红热是小儿常见的急性呼吸道传染病,属于我国乙类传染病。近年来我国猩红热发病率呈波动上升趋势,2022年WHO报道多国突发猩红热并造成死亡,当前尚未有猩红热疫苗预防,防控形势比较严峻。本文对近十年国内外公开发表的猩红热相关的中西医文献予以分析,发现其发病与A组链球菌及其基因分型、缓症链球菌感染、气象、五运六气相关。儿童是主要患病群体,猩红热发病具有时间、地域差异性。中医内服外用剂治疗猩红热疗效较好,中医治疗猩红热的机制及临床研究的深入挖掘对于猩红热进一步研究具有指导意义。

Scarlet fever is a common acute respiratory infectious disease in children,belonging to Class B infectious diseases in China.In recent years,the incidence rate of the disease fluctuated and increased in China.In 2022,WHO reported that scarlet fever broke out in many countries and caused death.At present,there is no vaccine against it,so its prevention and control situation is rather grim.This article analyzes the Chinese and western medical literature related to scarlet fever that has been publicly published in the past decade both at home and abroad,finding that its incidence is related to Group A hemolytic streptococcus and its genotype,streptococcus mitis infection,climate,and the five evolutive phases and six climatic factors.Besides,children are the main affected group,and the incidence of the disease varies in time and region.Traditional Chinese medicine(TCM)can achieve a good therapeutic effect in the treatment of scarlet fever through both oral and externally applied herbs.Therefore,an indepth exploration into the mechanisms and clinical research of traditional Chinese medicine in the treatment of scarlet fever has a guiding significance for its further research.